Use of metformin for prevention of ovarian hyperstimulation syndrome: A novel approach

Reproductive BioMedicine Online

Volumn 13, Issue 2, 2006, Pages 194-197

  Khattab, Sherif ^a   Fotouh, Ismail Aboul ^a   Mohesn, Iman Abdel ^a   Metwally, Mostapha ^a   Moaz, Mohamed ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Controlled clinical trial; IVF; Metformin; OHSS

Indexed keywords

CHORIMON; CHORIONIC GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; MERIONAL; METFORMIN; TRIPTORELIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COST; DRUG SAFETY; DRUG USE; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; MAJOR CLINICAL STUDY; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PREGNANCY RATE; PRIMARY PREVENTION; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE;

EID: 33747076922     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60614-1     Document Type: Article

References (25)

1. Aboulghar MA, Mansour RT 2003 Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Human Reproduction Update 9, 275-289.
2. Caballero AE, Delgado A, Aguilar-Salinas CA et al. 2004 The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: a placebo-controlled, randomized clinical trial. Journal of Clinical Endocrinology and Metabolism 89, 3943-3948.
3. Cheang KI, Nestler JE 2004 Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome? Reproductive BioMedicine Online 8, 440-447.
4. De Jager J, Kooy A, Lehert P et al. 2005 Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial. Journal of Internal Medicine 257, 100-109.
5. De Leo V, la Marca A, Ditto A et al. 1999 Effects of metformin on gonadotrophin-induced ovulation in women with polycystic ovary syndrome. Fertility and Sterility 72, 282-285.
6. Derosa G, Gaddi AV, Ciccarelli L et al. 2005 Long-term effect of glimepiride and rosiglitazone on non-conventional cardiovascular risk factors in metformin-treated patients affected by metabolic syndrome: a randomized, double-blind clinical trial. Journal of International Medical Research 33, 284-294.
7. Detaille D, Guigas B, Chauvin C et al. 2005 Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process. Diabetes 54, 2179-2187.
8. Diamanti-Kandarakis E, Alexandraki K, Protogerou A et al. 2005 Metformin administration improves endothelial function in women with polycystic ovary syndrome. European Journal of Endocrinology 152, 749-756.
9. Fedorcsak P, Dale PO, Storeng R et al. 2003 The effect of metformin on ovarian stimulation and on in vitro fertilization in insulin resistant women with polycystic ovary syndrome: an open-label randomized crossover trial. Gynecological Endocrinology 17, 207-214.
10. Genazzani AD, Battaglia C, Malavasi B et al. 2004 Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome. Fertility and Sterility 81, 114-119.
11. Goldsman MP, Pedram A, Dominguez CE et al. 1995 Increased capillary permeability induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome. Fertility and Sterility 63, 268-272.
12. Kjotrod SB, von During V, Carlsen SM 2004 Metformin treatment before IVF/ ICSI in women with polycystic ovary syndrome; a prospective, randomized, double blind study. Human Reproduction 19, 1315-1322.
13. Kumari AS, Haq A, Jayasundaram R et al. 2005 Metformin monotherapy in lean women with polycystic ovary syndrome. Reproductive BioMedicine Online 10, 100-104.
14. la Marca A, Morgante G, Palumbo M et al. 2002 Insulin-lowering treatment reduces aromatase activity in response to follicle-stimulating hormone in women with polycystic ovary syndrome. Fertility and Sterility 78, 1234-1239.
15. Onalan G, Pabuccu R, Goktolga U et al. 2005 Metformin treatment in patients with polycystic ovary syndrome undergoing in vitro fertilization: a prospective randomized trial. Fertility and Sterility 84, 798-801.
16. Orio F Jr, Palomba S, Cascella T et al. 2005 Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study. Journal of Clinical Endocrinology and Metabolism 90, 6072-6076.
17. Palomba S, Orio F Jr, Falbo A et al. 2005 Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome. Clinical Endocrinology (Oxford) 63, 631-635.
18. Pawelczyk L, Spaczynski RZ, Banaszewska B, Duleba AJ 2004 Metformin therapy increases insulin-like growth factor binding protein-1 in hyperinsulinemic women with polycystic ovary syndrome. European Journal of Obstetrics, Gynecology and Reproductive Biology 113, 209-213.
19. Rabau E, David A, Serr DM et al. 1967 Human menopausal gonadotrophin for anovulation and sterility. American Journal of Obstetrics and Gynecology 98, 92-98.
20. Sahin I, Serter R, Karakurt F et al. 2004 Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study. Gynecological Endocrinology 19, 115-124.
21. Stadtmauer LA, Toma SK, Riehl RM, Talbert LM 2001 Metformin treatment of patients with polycystic ovary syndrome undergoing in vitro fertilization improves outcomes and is associated with modulation of the insulin-like growth factors. Fertility and Sterility 75, 505-509.
22. Tsirigotis M, Craft I 1994 Ovarian hyperstimulation syndrome (OHSS): how much do we really know about it? European Journal of Obstetrics, Gynecology and Reproductive Biology 55, 151-155.
23. Unluhizarci K, Kelestimur F, Bayram F et al. 1999 The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome. Clinical Endocrinology (Oxf) 51, 231-236.
24. Visnova H, Ventruba P, Crha I, Zakova J 2003 [Importance of sensitization of insulin receptors in the prevention of ovarian hyperstimulation syndrome] Ceska Gynekologie 68, 155-162.
25. Vrbikova J, Hill M, Starka L et al. 2001 The effects of long-term metformin treatment on adrenal and ovarian steroidogenesis in women with polycystic ovary syndrome. European Journal of Endocrinology 144, 619-628.